Skip to main content

Guidelines for CSF Processing and Biobanking: Impact on the Identification and Development of Optimal CSF Protein Biomarkers

Part of the Methods in Molecular Biology book series (MIMB,volume 2044)

Abstract

The field of neurological diseases strongly needs biomarkers for early diagnosis and optimal stratification of patients in clinical trials or to monitor disease progression. Cerebrospinal fluid (CSF) is one of the main sources for the identification of novel protein biomarkers for neurological diseases. Despite the enormous efforts employed to identify novel CSF biomarkers, the high variability observed across different studies has hampered their validation and implementation in clinical practice. Such variability is partly caused by the effect of different pre-analytical confounding factors on protein stability, highlighting the importance to develop and comply with standardized operating procedures. In this chapter, we describe the international consensus pre-analytical guidelines for CSF processing and biobanking that have been established during the last decade, with a special focus on the influence of pre-analytical confounders on the global CSF proteome. In addition, we provide novel results on the influence of different delayed storage and freeze/thaw conditions on the CSF proteome using two novel large multiplex protein arrays (SOMAscan and Olink). Compliance to consensus guidelines will likely facilitate the successful development and implementation of CSF protein biomarkers in both research and clinical settings, ultimately facilitating the successful development of disease-modifying therapies.

Key words

  • CSF
  • Proteomics
  • Biomarkers
  • Neurology
  • Guidelines
  • Biobanking
  • Pre-analytical confounding factors
  • Stability
  • Reproducibility

This is a preview of subscription content, access via your institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-1-4939-9706-0_2
  • Chapter length: 24 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   109.00
Price excludes VAT (USA)
  • ISBN: 978-1-4939-9706-0
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   149.99
Price excludes VAT (USA)
Hardcover Book
USD   219.99
Price excludes VAT (USA)
Fig. 1
Fig. 2

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Rifai N, Gillette MA, Carr SA (2006) Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24(8):971–983. https://doi.org/10.1038/nbt1235

    CAS  CrossRef  PubMed  Google Scholar 

  2. Mattsson N (2011) CSF biomarkers in neurodegenerative diseases. Clin Chem Lab Med 49(3):345–352. https://doi.org/10.1515/CCLM.2011.082

    CAS  CrossRef  PubMed  Google Scholar 

  3. Blennow K, Hampel H, Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6(3):131–144. https://doi.org/10.1038/nrneurol.2010.4

    CAS  CrossRef  PubMed  Google Scholar 

  4. Schoonenboom NS, Mulder C, Vanderstichele H, Van Elk EJ, Kok A, Van Kamp GJ, Scheltens P, Blankenstein MA (2005) Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice. Clin Chem 51(1):189–195. https://doi.org/10.1373/clinchem.2004.039735

    CAS  CrossRef  PubMed  Google Scholar 

  5. Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R, Contributors (2018) NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement 14(4):535–562. https://doi.org/10.1016/j.jalz.2018.02.018

    CrossRef  PubMed  PubMed Central  Google Scholar 

  6. Plebani M, Sciacovelli L, Aita A, Chiozza ML (2014) Harmonization of pre-analytical quality indicators. Biochem Med (Zagreb) 24(1):105–113. https://doi.org/10.11613/BM.2014.012

    CrossRef  Google Scholar 

  7. Sunderland T, Linker G, Mirza N, Putnam KT, Friedman DL, Kimmel LH, Bergeson J, Manetti GJ, Zimmermann M, Tang B, Bartko JJ, Cohen RM (2003) Decreased Β-Amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA 289(16):2094–2103. https://doi.org/10.1001/jama.289.16.2094

    CrossRef  PubMed  Google Scholar 

  8. Mollenhauer B, El-Agnaf OMA, Marcus K, Trenkwalder C, Schlossmacher MG (2010) Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies. Biomark Med 4(5):683–699. https://doi.org/10.2217/bmm.10.90. https://www.futuremedicine.com/doi/abs/10.2217/bmm.10.90

    CAS  CrossRef  PubMed  Google Scholar 

  9. Mattsson N, Andreasson U, Persson S, Carrillo MC, Collins S, Chalbot S, Cutler N, Dufour-Rainfray D, Fagan AM, Heegaard NH, Robin Hsiung GY, Hyman B, Iqbal K, Kaeser SA, Lachno DR, Lleo A, Lewczuk P, Molinuevo JL, Parchi P, Regeniter A, Rissman RA, Rosenmann H, Sancesario G, Schroder J, Shaw LM, Teunissen CE, Trojanowski JQ, Vanderstichele H, Vandijck M, Verbeek MM, Zetterberg H, Blennow K, Alzheimer's Association QCPWG (2013) CSF biomarker variability in the Alzheimer’s association quality control program. Alzheimers Dement 9(3):251–261. https://doi.org/10.1016/j.jalz.2013.01.010

    CrossRef  PubMed  PubMed Central  Google Scholar 

  10. Lewczuk P, Beck G, Ganslandt O, Esselmann H, Deisenhammer F, Regeniter A, Petereit HF, Tumani H, Gerritzen A, Oschmann P, Schroder J, Schonknecht P, Zimmermann K, Hampel H, Burger K, Otto M, Haustein S, Herzog K, Dannenberg R, Wurster U, Bibl M, Maler JM, Reubach U, Kornhuber J, Wiltfang J (2006) International quality control survey of neurochemical dementia diagnostics. Neurosci Lett 409(1):1–4. https://doi.org/10.1016/j.neulet.2006.07.009

    CAS  CrossRef  PubMed  Google Scholar 

  11. Verwey NA, van der Flier WM, Blennow K, Clark C, Sokolow S, De Deyn PP, Galasko D, Hampel H, Hartmann T, Kapaki E, Lannfelt L, Mehta PD, Parnetti L, Petzold A, Pirttila T, Saleh L, Skinningsrud A, Swieten JC, Verbeek MM, Wiltfang J, Younkin S, Scheltens P, Blankenstein MA (2009) A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer’s disease. Ann Clin Biochem 46(Pt 3):235–240. https://doi.org/10.1258/acb.2009.008232

    CAS  CrossRef  PubMed  Google Scholar 

  12. Mattsson N, Zetterberg H, Blennow K (2010) Lessons from multicenter studies on CSF biomarkers for Alzheimer’s disease. Int J Alzheimers Dis 2010. https://doi.org/10.4061/2010/610613

    Google Scholar 

  13. Teunissen CE, Petzold A, Bennett JL, Berven FS, Brundin L, Comabella M, Franciotta D, Frederiksen JL, Fleming JO, Furlan R, Hintzen RQ, Hughes SG, Johnson MH, Krasulova E, Kuhle J, Magnone MC, Rajda C, Rejdak K, Schmidt HK, van Pesch V, Waubant E, Wolf C, Giovannoni G, Hemmer B, Tumani H, Deisenhammer F (2009) A consensus protocol for the standardization of CSF collection and biobank. Neurology 73:1914–1922

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  14. Deisenhammera F, Egga R, Giovannonib G, Hemmerc B, Petzoldd A, Sellebjerge F, Teunissen C, Tumanig H (2009) EFNS guidelines on disease-specific CSF investigations. Eur J Neurol 16:760–770. https://doi.org/10.1111/j.1468-1331.2009.02595.x

    CrossRef  Google Scholar 

  15. del Campo M, Mollenhauer B, Bertolotto A, Engelborghs S, Hampel H, Simonsen AH, Kapaki E, Kruse N, Le Bastard N, Lehmann S, Molinuevo JL, Parnetti L, Perret-Liaudet A, Saez-Valero J, Saka E, Urbani A, Vanmechelen E, Verbeek M, Visser PJ, Teunissen C (2012) Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update. Biomark Med 6(4):419–430. https://doi.org/10.2217/bmm.12.46

    CAS  CrossRef  PubMed  Google Scholar 

  16. Otto M, Bowser R, Turner M, Berry J, Brettschneider J, Connor J, Costa J, Cudkowicz M, Glass J, Jahn O, Lehnert S, Malaspina A, Parnetti L, Petzold A, Shaw P, Sherman A, Steinacker P, Sussmuth S, Teunissen C, Tumani H, Wuolikainen A, Ludolph A, Volcano G (2012) Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS. Amyotroph Lateral Scler 13(1):1–10. https://doi.org/10.3109/17482968.2011.627589

    CrossRef  PubMed  Google Scholar 

  17. Vanderstichele H, Bibl M, Engelborghs S, Le Bastard N, Lewczuk P, Molinuevo JL, Parnetti L, Perret-Liaudet A, Shaw LM, Teunissen C, Wouters D, Blennow K (2012) Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer’s disease diagnosis: a consensus paper from the Alzheimer’s biomarkers standardization initiative. Alzheimers Dement 8(1):65–73. https://doi.org/10.1016/j.jalz.2011.07.004

    CAS  CrossRef  PubMed  Google Scholar 

  18. Teunissen CE, Tumani H, Engelborghs S, Mollenhauer B (2014) Biobanking of CSF: international standardization to optimize biomarker development. Clin Biochem 47(4-5):288–292. https://doi.org/10.1016/j.clinbiochem.2013.12.024

    CrossRef  PubMed  Google Scholar 

  19. Willemse EAJ, Teunissen CE (2015) Importance of pre-analytical stability for CSF biomarker testing. Cerebrospinal Fluid Clin Neurol:59–77. https://doi.org/10.1007/978-3-319-01225-4_5

    Google Scholar 

  20. Willemse EAJ, Teunissen CE (2015) Biobanking of cerebrospinal fluid for biomarker analysis in neurological diseases. Adv Exp Med Biol 864:79–93. https://doi.org/10.1007/978-3-319-20579-3_7

    CrossRef  PubMed  Google Scholar 

  21. Andreasson U, Perret-Liaudet A, van Waalwijk van Doorn LJ, Blennow K, Chiasserini D, Engelborghs S, Fladby T, Genc S, Kruse N, Kuiperij HB, Kulic L, Lewczuk P, Mollenhauer B, Mroczko B, Parnetti L, Vanmechelen E, Verbeek MM, Winblad B, Zetterberg H, Koel-Simmelink M, Teunissen CE (2015) A practical guide to immunoassay method validation. Front Neurol 6:179. https://doi.org/10.3389/fneur.2015.00179

    CrossRef  PubMed  PubMed Central  Google Scholar 

  22. Engelborghs S, Niemantsverdriet E, Struyfs H, Blennow K, Brouns R, Comabella M, Dujmovic I, van der Flier W, Frolich L, Galimberti D, Gnanapavan S, Hemmer B, Hoff E, Hort J, Iacobaeus E, Ingelsson M, Jan de Jong F, Jonsson M, Khalil M, Kuhle J, Lleo A, de Mendonca A, Molinuevo JL, Nagels G, Paquet C, Parnetti L, Roks G, Rosa-Neto P, Scheltens P, Skarsgard C, Stomrud E, Tumani H, Visser PJ, Wallin A, Winblad B, Zetterberg H, Duits F, Teunissen CE (2017) Consensus guidelines for lumbar puncture in patients with neurological diseases. Alzheimers Dement (Amst) 8:111–126. https://doi.org/10.1016/j.dadm.2017.04.007

    CrossRef  Google Scholar 

  23. Hansson O, Mikulskis A, Fagan AM, Teunissen C, Zetterberg H, Vanderstichele H, Molinuevo JL, Shaw LM, Vandijck M, Verbeek MM, Savage M, Mattsson N, Lewczuk P, Batrla R, Rutz S, Dean RA, Blennow K (2018) The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer’s disease diagnosis: a review. Alzheimers Dement 14(10):1313–1333. https://doi.org/10.1016/j.jalz.2018.05.008

    CrossRef  PubMed  Google Scholar 

  24. Deisenhammer F, Bartos A, Egg R, Gilhus NE, Giovannoni G, Rauer S, Sellebjerg F, Force ET (2006) Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol 13(9):913–922. https://doi.org/10.1111/j.1468-1331.2006.01493.x

    CAS  CrossRef  PubMed  Google Scholar 

  25. Simonsen AH, Kuiperij B, Mukhtar O, El-Agnaf A, Engelborghs S, Herukka S, Parnetti L, Rektorova I, Vanmechelen E, Kapaki E, Verbeek M, Mollenhauer B (2015) The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature. Biomark Med 10(1)

    CAS  CrossRef  PubMed  Google Scholar 

  26. Gold L, Ayers D, Bertino J, Bock C, Bock A, Brody EN, Carter J, Dalby AB, Eaton BE, Fitzwater T, Flather D, Forbes A, Foreman T, Fowler C, Gawande B, Goss M, Gunn M, Gupta S, Halladay D, Heil J, Heilig J, Hicke B, Husar G, Janjic N, Jarvis T, Jennings S, Katilius E, Keeney TR, Kim N, Koch TH, Kraemer S, Kroiss L, Le N, Levine D, Lindsey W, Lollo B, Mayfield W, Mehan M, Mehler R, Nelson SK, Nelson M, Nieuwlandt D, Nikrad M, Ochsner U, Ostroff RM, Otis M, Parker T, Pietrasiewicz S, Resnicow DI, Rohloff J, Sanders G, Sattin S, Schneider D, Singer B, Stanton M, Sterkel A, Stewart A, Stratford S, Vaught JD, Vrkljan M, Walker JJ, Watrobka M, Waugh S, Weiss A, Wilcox SK, Wolfson A, Wolk SK, Zhang C, Zichi D (2010) Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS One 5(12):e15004. https://doi.org/10.1371/journal.pone.0015004

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  27. Carlyle BC, Trombetta BA, Arnold SE (2018) Proteomic approaches for the discovery of biofluid biomarkers of neurodegenerative dementias. Proteomes 6(3). https://doi.org/10.3390/proteomes6030032

    CrossRef  PubMed  PubMed Central  Google Scholar 

  28. Murillo-Rodriguez E, Desarnaud F, Prospero-Garcia O (2006) Diurnal variation of arachidonoylethanolamine, palmitoylethanolamide and oleoylethanolamide in the brain of the rat. Life Scienes 79(1):30–37. https://doi.org/10.1016/j.lfs.2005.12.028

    CAS  CrossRef  Google Scholar 

  29. Bjerke M, Portelius E, Minthon L, Wallin A, Anckarsater H, Anckarsater R, Andreasen N, Zetterberg H, Andreasson U, Blennow K (2010) Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid. Int J Alzheimers Dis 2010. https://doi.org/10.4061/2010/986310

    CrossRef  Google Scholar 

  30. Spies PE, Slats D, Rikkert MG, Tseng J, Claassen JA, Verbeek MM (2011) CSF alpha-synuclein concentrations do not fluctuate over hours and are not correlated to amyloid beta in humans. Neurosci Lett 504(3):336–338. https://doi.org/10.1016/j.neulet.2011.09.063

    CAS  CrossRef  PubMed  Google Scholar 

  31. Moghekar A, Goh J, Li M, Albert M, O'Brien RJ (2012) Cerebrospinal fluid Abeta and tau level fluctuation in an older clinical cohort. Arch Neurol 69(2):246–250. https://doi.org/10.1001/archneurol.2011.732

    CrossRef  PubMed  PubMed Central  Google Scholar 

  32. Slats D, Claassen JA, Spies PE, Borm G, Besse KT, van Aalst W, Tseng J, Sjogren MJ, Olde Rikkert MG, Verbeek MM (2012) Hourly variability of cerebrospinal fluid biomarkers in Alzheimer's disease subjects and healthy older volunteers. Neurobiol Aging 33(4):831 e831–831 e839. https://doi.org/10.1016/j.neurobiolaging.2011.07.008

    CAS  CrossRef  Google Scholar 

  33. Cicognola C, Chiasserini D, Parnetti L (2015) Preanalytical confounding factors in the analysis of cerebrospinal fluid biomarkers for Alzheimer’s disease: the issue of diurnal variation. Front Neurol 6:143. https://doi.org/10.3389/fneur.2015.00143

    CrossRef  PubMed  PubMed Central  Google Scholar 

  34. Cicognola C, Chiasserini D, Eusebi P, Andreasson U, Vanderstichele H, Zetterberg H, Parnetti L, Blennow K (2016) No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF. Mol Neurodegener 11(1):65. https://doi.org/10.1186/s13024-016-0130-3

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  35. Lucey BP, Fagan AM, Holtzman DM, Morris JC, Bateman RJ (2017) Diurnal oscillation of CSF Abeta and other AD biomarkers. Mol Neurodegener 12(1):36. https://doi.org/10.1186/s13024-017-0161-4

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  36. Engedal TS, Ording H, Vilholm OJ (2015) Changing the needle for lumbar punctures: results from a prospective study. Clin Neurol Neurosurg 130:74–79. https://doi.org/10.1016/j.clineuro.2014.12.020

    CrossRef  PubMed  Google Scholar 

  37. Duits FH, Martinez-Lage P, Paquet C, Engelborghs S, Lleo A, Hausner L, Molinuevo JL, Stomrud E, Farotti L, Ramakers I, Tsolaki M, Skarsgard C, Astrand R, Wallin A, Vyhnalek M, Holmber-Clausen M, Forlenza OV, Ghezzi L, Ingelsson M, Hoff EI, Roks G, de Mendonca A, Papma JM, Izagirre A, Taga M, Struyfs H, Alcolea DA, Frolich L, Balasa M, Minthon L, Twisk JWR, Persson S, Zetterberg H, van der Flier WM, Teunissen CE, Scheltens P, Blennow K (2016) Performance and complications of lumbar puncture in memory clinics: results of the multicenter lumbar puncture feasibility study. Alzheimers Dement 12(2):154–163. https://doi.org/10.1016/j.jalz.2015.08.003

    CrossRef  PubMed  Google Scholar 

  38. Kraut A, Marcellin M, Adrait A, Kuhn L, Louwagie M, Kieffer-Jaquinod S, Lebert D, Masselon CD, Dupuis A, Bruley C, Jaquinod M, Garin J, Gallagher-Gambarelli M (2009) Peptide storage: are you getting the best return on your investment? Defining optimal storage conditions for proteomic samples. J Proteome Res 8:3778–3378

    CAS  CrossRef  PubMed  Google Scholar 

  39. Perret-Liaudet A, Pelpel M, Tholance Y, Dumont B, Vanderstichele H, Zorzi W, ElMoualij B, Schraen S, Moreaud O, Gabelle A, Thouvenot E, Thomas-Anterion C, Touchon J, Krolak-Salmon P, Kovacs GG, Coudreuse A, Quadrio I, Lehmann S (2012) Cerebrospinal fluid collection tubes: a critical issue for Alzheimer disease diagnosis. Clin Chem 58(4):787–795

    CAS  CrossRef  PubMed  Google Scholar 

  40. Lehmann S, Schraen S, Quadrio I, Paquet C, Bombois S, Delaby C, Dorey A, Dumurgier J, Hirtz C, Krolak-Salmon P, Laplanche JL, Moreaud O, Peoc'h K, Rouaud O, Sablonniere B, Thouvenot E, Touchon J, Vercruysse O, Hugon J, Gabelle A, Pasquier F, Perret-Liaudet A (2014) Impact of harmonization of collection tubes on Alzheimer's disease diagnosis. Alzheimers Dement 10(5 Suppl):S390–S394 e392. https://doi.org/10.1016/j.jalz.2013.06.008

    CrossRef  PubMed  Google Scholar 

  41. Toombs A, Paterson RW, Schott JM, Zetterberg H (2014) Amyloid-beta 42 adsorption following serial tube transfer. Alzheimers Res Ther 6:5

    CrossRef  PubMed  PubMed Central  Google Scholar 

  42. Mollenhauer B, Batrla R, El-Agnaf O, Galasko DR, Lashuel HA, Merchant KM, Shaw LM, Selkoe DJ, Umek R, Vanderstichele H, Zetterberg H, Zhang J, Caspell-Garcia C, Coffey C, Hutten SJ, Frasier M, Taylor P, Investigating Synuclein Consortium of the Michael JFFfPsR (2017) A user’s guide for alpha-synuclein biomarker studies in biological fluids: perianalytical considerations. Mov Disord 32(8):1117–1130. https://doi.org/10.1002/mds.27090

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  43. Reijs BL, Teunissen CE, Goncharenko N, Betsou F, Blennow K, Baldeiras I, Brosseron F, Cavedo E, Fladby T, Froelich L, Gabryelewicz T, Gurvit H, Kapaki E, Koson P, Kulic L, Lehmann S, Lewczuk P, Lleo A, Maetzler W, de Mendonca A, Miller AM, Molinuevo JL, Mollenhauer B, Parnetti L, Rot U, Schneider A, Simonsen AH, Tagliavini F, Tsolaki M, Verbeek MM, Verhey FR, Zboch M, Winblad B, Scheltens P, Zetterberg H, Visser PJ (2015) The central biobank and virtual biobank of BIOMARKAPD: a resource for studies on neurodegenerative diseases. Front Neurol 6:216. https://doi.org/10.3389/fneur.2015.00216

    CrossRef  PubMed  PubMed Central  Google Scholar 

  44. Willemse E, van Uffelen K, Brix B, Engelborghs S, Vanderstichele H, Teunissen C (2017) How to handle adsorption of cerebrospinal fluid amyloid beta (1-42) in laboratory practice? Identifying problematic handlings and resolving the issue by use of the Abeta42/Abeta40 ratio. Alzheimers Dement 13(8):885–892. https://doi.org/10.1016/j.jalz.2017.01.010

    CrossRef  PubMed  Google Scholar 

  45. Pica-Mendez AM, Tanen M, Dallob A, Tanaka W, Laterza OF (2010) Nonspecific binding of Abeta42 to polypropylene tubes and the effect of Tween-20. Clin Chim Acta 411(21-22):1833. https://doi.org/10.1016/j.cca.2010.07.019

    CAS  CrossRef  PubMed  Google Scholar 

  46. Simonsen AH, Bech S, Laursen I, Salvesen L, Winge K, Waldemar G, Werdelin L, Nielsen JE, McGuire JN, Hjermind LE (2010) Proteomic investigations of the ventriculo-lumbar gradient in human CSF. J Neurosci Methods 191(2):244–248. https://doi.org/10.1016/j.jneumeth.2010.06.017

    CAS  CrossRef  PubMed  Google Scholar 

  47. Tarnaris A, Toma AK, Chapman MD, Petzold A, Keir G, Kitchen ND, Watkins LD (2011) Rostrocaudal dynamics of CSF biomarkers. Neurochem Res 36(3):528–532. https://doi.org/10.1007/s11064-010-0374-1

    CAS  CrossRef  PubMed  Google Scholar 

  48. Brandner S, Thaler C, Lewczuk P, Lelental N, Buchfelder M, Kleindienst A (2013) Neuroprotein dynamics in the cerebrospinal fluid: intraindividual concomitant ventricular and lumbar measurements. Eur Neurol 70(3-4):189–194. https://doi.org/10.1159/000352032

    CrossRef  PubMed  Google Scholar 

  49. Reiber H (2003) Proteins in cerebrospinal fluid and blood, barriers, CSF flow rate and source-related dynamics. Restor Neurol Neurosci 21:79–96

    CAS  PubMed  Google Scholar 

  50. Axel Petzold A, Sharpe LT, Keir G (2006) Spectrophotometry for cerebrospinal fluid pigment analysis. Neurocrit Care 4(6):153–162. https://doi.org/10.1385/Neurocrit

    CrossRef  PubMed  Google Scholar 

  51. You J-S, Gelfanova V, Knierman MD, Witzmann FA, Wang M, Hale JE (2005) The impact of blood contamination on the proteome of cerebrospinal fluid. Proteomics 5(1):290–296. https://doi.org/10.1002/pmic.200400889

    CAS  CrossRef  PubMed  Google Scholar 

  52. Yang J, Dombrowski SM, Deshpande A, Krajcir N, El-Khoury S, Krishnan C, Luciano MG (2011) Stability analysis of vascular endothelial growth factor in cerebrospinal fluid. Neurochem Res 36(11):1947–1954. https://doi.org/10.1007/s11064-011-0517-z

    CAS  CrossRef  PubMed  Google Scholar 

  53. Ramont L, Thoannes H, Volondat A, Chastang F, Millet MC, Maquart FX (2005) Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice. Clin Chem Lab Med 43(11):1215–1217. https://doi.org/10.1515/CCLM.2005.210

    CAS  CrossRef  PubMed  Google Scholar 

  54. Jimenez CR, Koel-Simmelink M, Pham TV, van der Voort L, Teunissen CE (2007) Endogeneous peptide profiling of cerebrospinal fluid by MALDI-TOF mass spectrometry: optimization of magnetic bead-based peptide capture and analysis of preanalytical variables. Proteomics Clin Appl 1(11):1385–1392. https://doi.org/10.1002/prca.200700330

    CAS  CrossRef  PubMed  Google Scholar 

  55. Berven FS, Kroksveen AC, Berle M, Rajalahti T, Flikka K, Arneberg R, Myhr KM, Vedeler C, Kvalheim OM, Ulvik RJ (2007) Pre-analytical influence on the low molecular weight cerebrospinal fluid proteome. Proteomics Clin Appl 1(7):699–711. https://doi.org/10.1002/prca.200700126

    CAS  CrossRef  PubMed  Google Scholar 

  56. Aasebo E, Opsahl JA, Bjorlykke Y, Myhr KM, Kroksveen AC, Berven FS (2014) Effects of blood contamination and the rostro-caudal gradient on the human cerebrospinal fluid proteome. PLoS One 9(3):e90429. https://doi.org/10.1371/journal.pone.0090429

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  57. O'Bryant SE, Gupta V, Henriksen K, Edwards M, Jeromin A, Lista S, Bazenet C, Soares H, Lovestone S, Hampel H, Montine T, Blennow K, Foroud T, Carrillo M, Graff-Radford N, Laske C, Breteler M, Shaw L, Trojanowski JQ, Schupf N, Rissman RA, Fagan AM, Oberoi P, Umek R, Weiner MW, Grammas P, Posner H, Martins R, Star B, groups Bw (2015) Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer’s disease research. Alzheimers Dement 11(5):549–560. https://doi.org/10.1016/j.jalz.2014.08.099

    CrossRef  PubMed  Google Scholar 

  58. Fehlbaum-Beurdeley P, Jarrige-Le Prado AC, Pallares D, Carriere J, Guihal C, Soucaille C, Rouet F, Drouin D, Sol O, Jordan H, Wu D, Lei L, Einstein R, Schweighoffer F, Bracco L (2010) Toward an Alzheimer’s disease diagnosis via high-resolution blood gene expression. Alzheimers Dement 6(1):25–38. https://doi.org/10.1016/j.jalz.2009.07.001

    CAS  CrossRef  PubMed  Google Scholar 

  59. Koel-Simmelink MJ, Vennegoor A, Killestein J, Blankenstein MA, Norgren N, Korth C, Teunissen CE (2014) The impact of pre-analytical variables on the stability of neurofilament proteins in CSF, determined by a novel validated SinglePlex Luminex assay and ELISA. J Immunol Methods 402(1-2):43–49. https://doi.org/10.1016/j.jim.2013.11.008

    CAS  CrossRef  PubMed  Google Scholar 

  60. Willemse EAJ, Durieux-Lu S, van der Flier WM, Pijnenburg YAL, de Jonge R, Teunissen CE (2016) Stability of progranulin under preanalytical conditions in serum and cerebrospinal fluid. J Alzheimers Dis 53(1):107–116

    CAS  CrossRef  PubMed  Google Scholar 

  61. Persichetti E, Chiasserini D, Parnetti L, Eusebi P, Paciotti S, De Carlo C, Codini M, Tambasco N, Rossi A, El-Agnaf OM, Calabresi P, Beccari T (2014) Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid. PLoS One 9(7):e101453. https://doi.org/10.1371/journal.pone.0101453

    CrossRef  PubMed  PubMed Central  Google Scholar 

  62. Bruegel M, Planert M, Baumann S, Focke A, Bergh FT, Leichtle A, Ceglarek U, Thiery J, Fiedler GM (2009) Standardized peptidome profiling of human cerebrospinal fluid by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Proteome 72(4):608–615. https://doi.org/10.1016/j.jprot.2008.11.018

    CAS  CrossRef  Google Scholar 

  63. Simonsen AH, Bahl JM, Danborg PB, Lindstrom V, Larsen SO, Grubb A, Heegaard NH, Waldemar G (2013) Pre-analytical factors influencing the stability of cerebrospinal fluid proteins. J Neurosci Methods 215(2):234–240. https://doi.org/10.1016/j.jneumeth.2013.03.011

    CAS  CrossRef  PubMed  Google Scholar 

  64. Klener J, Hofbauerova K, Bartos A, Ricny J, Ripova D, Kopecky V (2014) Instability of cerebrospinal fluid after delayed storage and repeated freezing: a holistic study by drop coating deposition Raman spectroscopy. Clin Chem Lab Med 52(5):657–664. https://doi.org/10.1515/cclm-2013-0800

    CAS  CrossRef  PubMed  Google Scholar 

  65. Rosenling T, Slim CL, Christin C, Coulier L, Shi S, Stoop MP, Bosman J, Suits F, Horvatovich PL, Stockhofe-Zurwieden N, Vreeken R, Hankemeier T, van Gool AJ, Luider TM, Bischoff R (2009) The effect of preanalytical factors on stability of the proteome and selected metabolites in CSF. J Proteome Res 8(12):5511–5522

    CAS  CrossRef  PubMed  Google Scholar 

  66. Toombs J, Paterson RW, Lunn MP, Nicholas JM, Fox NC, Chapman MD, Schott JM, Zetterberg H (2013) Identification of an important potential confound in CSF AD studies: aliquot volume. Clin Chem Lab Med 51(12):2311–2317. https://doi.org/10.1515/cclm-2013-0293

    CAS  CrossRef  PubMed  Google Scholar 

  67. Vanderstichele HM, Janelidze S, Demeyer L, Coart E, Stoops E, Herbst V, Mauroo K, Brix B, Hansson O (2016) Optimized standard operating procedures for the analysis of cerebrospinal fluid Abeta42 and the ratios of Abeta isoforms using low protein binding tubes. J Alzheimers Dis 53(3):1121–1132. https://doi.org/10.3233/JAD-160286

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  68. Delaby C, Munoz L, Torres S, Nadal A, Le Bastard N, Lehmann S, Lleo A, Alcolea D (2019) Impact of CSF storage volume on the analysis of Alzheimer’s disease biomarkers on an automated platform. Clin Chim Acta 490:98–101. https://doi.org/10.1016/j.cca.2018.12.021

    CAS  CrossRef  PubMed  Google Scholar 

  69. Willemse EA, Koel-Simmelink MJ, Durieux-Lu S, van der Flier WM, Teunissen CE (2015) Standard biobanking conditions prevent evaporation of body fluid samples. Clin Chim Acta 442:141–145. https://doi.org/10.1016/j.cca.2015.01.036

    CAS  CrossRef  PubMed  Google Scholar 

  70. Leitao MJ, Baldeiras I, Herukka SK, Pikkarainen M, Leinonen V, Simonsen AH, Perret-Liaudet A, Fourier A, Quadrio I, Veiga PM, de Oliveira CR (2015) Chasing the effects of pre-analytical confounders - a multicenter study on CSF-AD biomarkers. Front Neurol 6:153. https://doi.org/10.3389/fneur.2015.00153

    CrossRef  PubMed  PubMed Central  Google Scholar 

  71. Poulsen K, Bahl JM, Tanassi JT, Simonsen AH, Heegaard NH (2012) Characterization and stability of transthyretin isoforms in cerebrospinal fluid examined by immunoprecipitation and high-resolution mass spectrometry of intact protein. Methods 56(2):284–292. https://doi.org/10.1016/j.ymeth.2011.12.009

    CAS  CrossRef  PubMed  Google Scholar 

  72. Carrette O, Burkhard PR, Hughes S, Hochstrasser DF, Sanchez JC (2005) Truncated cystatin C in cerebrospiral fluid: technical [corrected] artefact or biological process? Proteomics 5(12):3060–3065. https://doi.org/10.1002/pmic.200402039

    CrossRef  PubMed  Google Scholar 

  73. Willemse EAJ, van Uffelen KWJ, van der Flier WM, Teunissen CE (2017) Effect of long-term storage in biobanks on cerebrospinal fluid biomarker Abeta1-42, T-tau, and P-tau values. Alzheimers Dement (Amst) 8:45–50. https://doi.org/10.1016/j.dadm.2017.03.005

    CrossRef  Google Scholar 

  74. van der Flier WM, Pijnenburg YA, Prins N, Lemstra AW, Bouwman FH, Teunissen CE, van Berckel BN, Stam CJ, Barkhof F, Visser PJ, van Egmond E, Scheltens P (2014) Optimizing patient care and research: the Amsterdam dementia cohort. J Alzheimers Dis 41(1):313–327. https://doi.org/10.3233/JAD-132306

    CrossRef  PubMed  Google Scholar 

  75. SomaLogic Inc., SOMAscan technical note

    Google Scholar 

  76. Molinuevo JL, Ayton S, Batrla R, Bednar MM, Bittner T, Cummings J, Fagan AM, Hampel H, Mielke MM, Mikulskis A, O'Bryant S, Scheltens P, Sevigny J, Shaw LM, Soares HD, Tong G, Trojanowski JQ, Zetterberg H, Blennow K (2018) Current state of Alzheimer's fluid biomarkers. Acta Neuropathol 136(6):821–853. https://doi.org/10.1007/s00401-018-1932-x

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  77. Kvartsberg H, Portelius E, Andreasson U, Brinkmalm G, Hellwig K, Lelental N, Kornhuber J, Hansson O, Minthon L, Spitzer P, Maler JM, Zetterberg H, Blennow K, Lewczuk P (2015) Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls. Alzheimers Res Ther 7(1):40. https://doi.org/10.1186/s13195-015-0124-3

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yanaika S. Hok-A-Hin .

Editor information

Editors and Affiliations

1 Electronic Supplementary Materials

Data 1

(PPTX 568 kb)

Data 2

(PPTX 478 kb)

Rights and permissions

Reprints and Permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Verify currency and authenticity via CrossMark

Cite this protocol

Hok-A-Hin, Y.S., Willemse, E.A.J., Teunissen, C.E., Del Campo, M. (2019). Guidelines for CSF Processing and Biobanking: Impact on the Identification and Development of Optimal CSF Protein Biomarkers. In: Santamaría, E., Fernández-Irigoyen, J. (eds) Cerebrospinal Fluid (CSF) Proteomics. Methods in Molecular Biology, vol 2044. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9706-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-9706-0_2

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-4939-9705-3

  • Online ISBN: 978-1-4939-9706-0

  • eBook Packages: Springer Protocols